7030B-C5
7030B-C5 is a PCSK9 inhibitor (IC50=1.61 μM) . 7030B-C5 can significantly reduce plasma cholesterol and triglyceride (TG) levels in vivo and slow the progression of atherosclerosis. 7030B-C5 can be used in the study of cardiovascular diseases[1].
Product Specifications
CAS Number
370871-42-4
UNSPSC
12352005
Target
PCSK9
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/7030b-c5.html
Purity
99.78
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1C2=C(N=C(NCCO)N2CC3=CC=CC(OC)=C3)N(C)C(N1C)=O
Molecular Formula
C17H21N5O4
Molecular Weight
359.38
References & Citations
[1]Xuhui Bao, et al. "Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) : from bench to bedside." Signal Transduction and Targeted Therapy 9.1 (2024) : 13.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC400523 20 µg
p38 (MAPK14) (NM_001315) Human Over-expression Lysate
Sign In for Pricing
View Details 
BNCB2131-100 1x 100 µL
Mesothelin (Mesothelial Marker) (MSLN/2131), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUM3186-50 1x 50 µL
S100A4 / Metastasin / Calvasculin (Marker of Tumor Metastasis) (rS100A4/1481), 1mg/mL
Sign In for Pricing
View Details 
TP321555M 100 µg
ARMET (MANF) (NM_006010) Human Recombinant Protein
Sign In for Pricing
View Details 